This article has been updated with information from Hologic's earnings presentation.

NEW YORK (GenomeWeb) – Hologic reported after the close of the market Wednesday that revenues for its first quarter of fiscal year 2017 were up around 6 percent year over year, driven in part by strong growth in molecular diagnostics product revenues. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.